Special report: cost-effectiveness of left-ventricular assist devices as destination therapy for end-stage heart failure.
D054598:Blue Cross Blue Shield Insurance Plans; D003362:Cost-Benefit Analysis; D018795:Device Approval; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000601:surgery*; D016027:Heart Transplantation; D006353:Heart-Assist Devices / Q000191:economics*; D006801:Humans; D019458:Insurance Coverage; D017063:Outcome Assessment, Health Care; D019057:Quality-Adjusted Life Years; D013673:Technology Assessment, Biomedical; D014481:United States; D014486:United States Food and Drug Administration